PointState Capital’s Thermo Fisher Scientific TMO Stock Holding History

PointState Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-90,154	Closed	-$49.9M	–	71
2024 Q2	$49.9M	Sell	90,154 -18,178	-17%	-$10.4M	1.08%	32
2024 Q1	$63M	Buy	+108,332	New	+$60.8M	1.08%	27
2022 Q1	–	Sell	-15,200	Closed	-$10.1M	–	126
2021 Q4	$10.1M	Buy	15,200 +10,200	+204%	+$6.37M	0.17%	61
2021 Q3	$2.86M	Sell	5,000 -5,000	-50%	-$2.74M	0.05%	113
2021 Q2	$5.04M	Sell	10,000 -1,000	-9%	-$472K	0.09%	95
2021 Q1	$5.02M	Buy	11,000 +1,550	+16%	+$740K	0.1%	97
2020 Q4	$4.4M	Buy	+9,450	New	+$4.43M	0.08%	98

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PointState Capital's TMO Position: Q3 2024 in Review

PointState Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 90,154 shares — an estimated $49.9M sold.

PointState Capital first reported a position in TMO in Q4 2020 and held it in 7 quarters. The position peaked at $63M in Q1 2024. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

PointState Capital reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
PointState Capital sold 90,154 Thermo Fisher Scientific shares in Q3 2024, an estimated $49.9M.
PointState Capital first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 7 quarters.
PointState Capital's Thermo Fisher Scientific position peaked at $63M in Q1 2024.
2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on PointState Capital's 13F filing for Q3 2024, filed 14 Nov 2024.